An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Popularity Via Social Media
Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to message these accounts directly for source information, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a robust trade exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and claims of rapid UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for transactions.
Learning About Retatrutide
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could result in users injecting substances of uncertain source.
Several experts said the popularity for the experimental drug could be connected to the rising cost of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.
Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or imprisonment.
Service Response and Material Elimination
According to the social media company, the service has taken down violative material and banned associated hashtags and search suggestions. The company said it was committed to maintaining the service safe and investing in strengthening compliance measures.
Online Trading Activities
Research also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, filled with images of slimming results, glowing testimonials and detailed guides for mixing or administering at home.
After moments of joining one group, a vendor posted contact information, where most purchases occur. The seller sent an guidebook and promised shipping within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Product Details and Pricing
Inside these communities, posts show black plastic parcels with Royal Mail stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how long a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for the messaging service said it actively moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is sound, these online versions may not contain what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.
Her team has previously seen patients injured by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject patients to possibly significant medical dangers”.
